Research Topics
| Peter McIntyreSummaryAffiliation: The Children's Hospital at Westmead Country: Australia Publications
| Collaborators
|
Detail Information
Publications
Human papillomavirus prevalence among indigenous and non-indigenous Australian women prior to a national HPV vaccination programSuzanne M Garland
Regional World Health Organisation Human Papillomavirus Laboratory Network, Department of Microbiology and Infectious Diseases, The Royal Women s Hospital, Locked Bag 300, Parkville, Victoria 3052, Australia
BMC Med 9:104. 2011..Prior to introduction of a national human papilloma virus (HPV) vaccination program, we determined HPV genotype prevalence by Indigenous status and residence in remote areas...
Vaccines for other neonatal infections: vaccination strategies for the prevention of neonatal pertussisPeter McIntyre
National Center for Immunization Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead, New South Wales, Australia
Expert Rev Vaccines 3:375-8. 2004....
High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria-tetanus-acellular pertussis vaccinePeter B McIntyre
Centre for Immunisation Research, University of Sydney and the Royal Alexandra Hospital for Children, Locked Bag 4001, Westmead, NSW 2145, Australia
Vaccine 23:380-5. 2004..Adult-formulated dTpa vaccines could replace Td for routine booster vaccination of older individuals...
Booster vaccination of adults with reduced-antigen-content diphtheria, Tetanus and pertussis vaccine: immunogenicity 5 years post-vaccinationPeter B McIntyre
National Centre for Immunisation Research and Surveillance, University of Sydney and The Children s Hospital at Westmead, Australia
Vaccine 27:1062-6. 2009..5% and 90.6% of pa vaccine recipients. At 5 years post boosting, antibody levels to diphtheria and tetanus are similar amongst adults receiving a dTpa or dT, and pertussis antibodies remain above pre-booster levels in at least 85%...
Pertussis in early infancy: disease burden and preventive strategiesPeter McIntyre
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, Australia
Curr Opin Infect Dis 22:215-23. 2009..We review current understanding of the disease burden and potential prevention strategies...
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006Robert Menzies
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Australia
Commun Dis Intell 32:S2-67. 2008..Immunisation programs are an example of how preventive health programs in general can be enhanced to close the gap in morbidity and mortality between Indigenous and non-Indigenous Australians...
Acellular pertussis vaccine at birth and one month induces antibody responses by two months of ageNicholas Wood
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, New South Wales, Australia
Pediatr Infect Dis J 29:209-15. 2010..Several studies have examined antibody responses to pertussis vaccines at birth but no previous study has evaluated 2 doses of monovalent acellular pertussis vaccine (aPV) before 2 months of age...
Surveillance of adverse events following immunisation: Australia 2002 to 2003Glenda Lawrence
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children s Hospital at Westmead, Westmead, New South Wales
Commun Dis Intell 28:324-38. 2004..The low reporting rate of serious AEFIs demonstrates the high level of safety of vaccines in Australia...
Annual report: Surveillance of adverse events following immunisation in Australia, 2005Glenda Lawrence
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children s Hospital at Westmead, Sydney, New South Wales
Commun Dis Intell 30:319-33. 2006..The consistently low reporting rate of serious AEFIs demonstrates the high level of safety of vaccines in Australia...
Vaccination for the paediatricianNicholas Wood
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead and the University of Sydney, Department of Allergy, Immunology and Infectious Diseases, NSW, Australia
J Paediatr Child Health 42:665-73. 2006..The first part of this article discusses groups with special vaccination requirements. The second part discusses the use of individual vaccines in these children...
Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccinationVeronica Kolos
University of Sydney, Australia
Vaccine 25:588-90. 2007..These data suggest that residence in a remote area, as a proxy for poorer living conditions for indigenous people, and delayed vaccination, both contribute to higher pertussis hospitalization rates in indigenous infants...
Vaccine preventable diseases and vaccination policy for indigenous populationsRobert Menzies
The National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Sydney, New South Wales, Australia
Epidemiol Rev 28:71-80. 2006..In national programs targeting only indigenous people, it has been difficult to achieve high coverage, particularly in urban areas. Innovative program approaches are particularly needed in these situations...
Annual report: surveillance of adverse events following immunisation in Australia, 2008Rob Menzies
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, The Children s Hospital at Westmead, Sydney, New South Wales
Commun Dis Intell 33:365-81. 2009..The consistently low reporting rate of serious AEFI highlights the safety of vaccines in Australia and illustrates the value of the national TGA database as a surveillance tool for monitoring AEFIs nationally...
Trends in invasive Haemophilus influenzae type B disease in Australia, 1995-2005Han Wang
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead, New South Wales
Commun Dis Intell 32:316-25. 2008..Continued enhanced surveillance for invasive Hib disease is important for optimal monitoring of trends into the future...
Anaphylaxis following quadrivalent human papillomavirus vaccinationJulia M L Brotherton
National Centre for Immunisation Research and Surveillance, The Children s Hospital at Westmead and University of Sydney, NSW, Australia
CMAJ 179:525-33. 2008..Following notification of 7 presumptive cases of anaphylaxis in the state of New South Wales, Australia, we verified cases and compared the incidence of anaphylaxis following HPV vaccination to other vaccines in comparable settings...
Implementation of mandatory immunisation of healthcare workers: observations from New South Wales, AustraliaCharles Helms
University of Sydney, Australia
Vaccine 29:2895-901. 2011..Vaccines included were measles, mumps, rubella, varicella, hepatitis B, diphtheria, tetanus and pertussis, but not influenza...
Cough symptoms in children aged 5-14 years in Sydney, Australia: non-specific cough or unrecognized pertussis?Michelle Cagney
School of Public Health, University of Sydney, Sydney, Australia
Respirology 10:359-64. 2005..The aim of this study was to estimate the community prevalence of coughing symptoms, consistent with surveillance definitions for pertussis, and doctor-diagnosed pertussis in children aged 5-14 years...
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002Robert Menzies
National Centre for Immunisation Research and Surveillance, The Children s Hospital at Westmead, Locked Bag 4001, Westmead, NSW 2145
Commun Dis Intell 28:127-59. 2004..Such issues need to be considered and implemented in full cooperation with Aboriginal and Torres Strait Islander people...
Pertussis in infants: preventing deaths and hospitalisations in the very youngNicholas Wood
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, Sydney, New South Wales, Australia
J Paediatr Child Health 44:161-5. 2008....
Pertussis: review of epidemiology, diagnosis, management and preventionNicholas Wood
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead, University of Sydney, New South Wales, Australia
Paediatr Respir Rev 9:201-11; quiz 211-2. 2008..This paper reviews the current epidemiology of pertussis in developed countries, including modes of clinical presentation, diagnosis, management and potential vaccination strategies...
Management of children with otitis media: a summary of evidence from recent systematic reviewsHasantha Gunasekera
Centre for Kidney Research, The Children s Hospital at Westmead, Westmead, NSW, Australia
J Paediatr Child Health 45:554-62; quiz 562-3. 2009..In this review, we seek to summarise the current best evidence for answering otitis media management questions by collating existing systematic reviews...
Vaccine preventable diseases in indigenous populations - International perspectives. Satellite Symposium of the 5th International Symposium on Pneumococci and Pneumococcal Diseases, April 2006, Alice Springs, AustraliaRob Menzies
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, New South Wales 2145, Australia
Vaccine 25:7281-4. 2007
National study of infants hospitalized with pertussis in the acellular vaccine eraElizabeth Elliott
Discipline of Paediatrics and Child Health, The University of Sydney and The Children s Hospital at Westmead, Sydney, Australia
Pediatr Infect Dis J 23:246-52. 2004..Few data are available on pertussis hospitalizations or sources of infection in countries exclusively using DTPa...
Has pertussis increased in NSW over the past decade? An evaluation using hospitalisation and mortality data versus notifications 1988-2002Rob Menzies
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead
N S W Public Health Bull 14:71-6. 2003
Differences in the epidemiology of invasive pneumococcal disease, metropolitan NSW, 1997-2001Peter McIntyre
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead
N S W Public Health Bull 14:85-9. 2003
Establishment of a surveillance system (utilising Midwifes Data Collection Systems) for monitoring the impact of hepatitis B vaccination on the population prevalence of chronic hepatitis B virus infection in AustraliaNicholas Wood
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases NCIRS, Westmead, NSW, Australia
Aust N Z J Public Health 32:272-5. 2008....
Progress towards eliminating Hib in Australia: an evaluation of Haemophilus influenzae type b prevention in Australia, 1 July 1993 to 30 June 2000Peter Horby
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, NSW
Commun Dis Intell 27:324-41. 2003..Nevertheless, experience in Australia and elsewhere indicates that continued careful monitoring of Hib disease, with high quality laboratory surveillance, remains important...
Do variations in pertussis notifications reflect incidence or surveillance practices? A comparison of infant notification rates and hospitalisation data in NSWSiranda Torvaldsen
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney, Westmead
N S W Public Health Bull 14:81-4. 2003
Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in AustraliaNicholas Wood
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, New South Wales, Australia
Pediatr Infect Dis J 31:199-202. 2012..These data are reassuring for parents and healthcare workers regarding 2011 influenza vaccination in the northern hemisphere...
Are general practice registrars prepared for immunisation? A cross sectional surveyJulie Leask
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead, and the University of Sydney, New South Wales
Aust Fam Physician 33:665-7. 2004..To describe undergraduate formal training on immunisation as remembered by general practice registrars and its perceived helpfulness...
The spectrum and management of otitis media in Australian indigenous and nonindigenous children: a national studyHasantha Gunasekera
Centre for Kidney Research, The Children s Hospital, Westmead, Sydney, Australia
Pediatr Infect Dis J 26:689-92. 2007..Indigenous children have the highest reported prevalence and severity of otitis media in the world, but whether their clinical management varies accordingly is unknown...
Public opponents of vaccination: a case studyJulie Leask
National Centre for Immunisation Research and Surveillance, Children s Hospital at Westmead, University of Sydney, Locked Bag 4001, Westmead 2145, Australia
Vaccine 21:4700-3. 2003..We conclude by suggesting how health professionals might respond in the public arena...
Surveillance of adverse events following immunisation: Australia, 2000-2002Glenda Lawrence
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Children s Hospital at Westmead, and the University of Sydney, New South Wales
Commun Dis Intell 27:307-23. 2003....
Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002Robert Menzies
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases
Commun Dis Intell 28:S1-45. 2004
Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccineTerry Nolan
The University of Melbourne, Department of Paediatrics, and Murdoch Children s Research Institute at the Royal Children s Hospital, Melbourne, Australia
Vaccine 21:281-9. 2002..This tetravalent MMRV candidate vaccine showed promising results, although further examination of the possible increase in minor fever and decreased varicella immunogenicity should be assessed in future studies...
Using computer simulations to compare pertussis vaccination strategies in AustraliaHerbert W Hethcote
Department of Mathematics, University of Iowa, 14 MacLean Hall, Iowa City, IA 52242, USA
Vaccine 22:2181-91. 2004....
Lessons from surveillance; solving the pertussis puzzlePeter McIntyre
N S W Public Health Bull 14:69-71. 2003
Pneumococcal disease in Australia: current status and future challenges. A report of the workshop held at the National Centre for Immunisation Research and Surveillance, 8-9 November, 2002Paul Roche
Surveillance and Epidemiology Section, Department of Health and Ageing, Canberra, Australian Capital Territory
Commun Dis Intell 27:79-84. 2003..Improving the identification of Aboriginal and Torres Strait Islander children is important, especially in urban areas...
Australia's notifiable diseases status, 2006: annual report of the National Notifiable Diseases Surveillance SystemKylie Begg
Office of Health Protection, Australian Government Department of Health and Ageing, Canberra, Australian Capital Territory
Commun Dis Intell 32:139-207. 2008..There were 19,111 notifications of bloodborne diseases; 8,606 notifications of vectorborne diseases; 1,900 notifications of other bacterial infections; 767 notifications of zoonoses and 3 notifications of quarantinable diseases...
Vaccine preventable diseases and vaccination coverage in Australia 2001 to 2002Julia Brotherton
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS
Commun Dis Intell 28:vii-S116. 2004
The cost-effectiveness of pneumococcal conjugate vaccination in AustraliaJames R G Butler
National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australia
Vaccine 22:1138-49. 2004..The impact of PCV7 against non-bacteraemic pneumonia is poorly defined, but its importance to cost-effectiveness in resource rich and resource poor settings warrants further studies or analysis to give greater precision to this outcome...
Vaccine preventable diseases and vaccination coverage in Australia, 2003 to 2005Julia Brotherton
National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS
Commun Dis Intell 31:S1-152. 2007
Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months oldRobert B Belshe
Division of Infectious Diseases and Immunology, Saint Louis University, St Louis, Missouri, USA
J Infect Dis 189:462-70. 2004..PIV3-cp45 vaccine was safe and immunogenic in seronegative children and should be evaluated for efficacy in a phase 3 field trial...
Vaccine preventable diseases and vaccination coverage in Australia, 1999 to 2000Peter McIntyre
Commun Dis Intell . 2002
Cloning and functional characterization of the guinea pig vanilloid receptor 1Jonathan Savidge
Novartis Institute for Medical Sciences, 5 Gower Place, WC1E 6BN, London, UK
Neuropharmacology 43:450-6. 2002..5, and provided complete blockade of heat responses at 1 micro M. Thus, capsazepine can significantly inhibit calcium influx due to heat and pH 5.5 at guinea pig VR1 and human VR1 but is inactive against these activators at rat VR1...
Refusal of parents to vaccinate: dereliction of duty or legitimate personal choice?Peter McIntyre
Med J Aust 178:150-1. 2003
Identification and biological characterization of 6-aryl-7-isopropylquinazolinones as novel TRPV1 antagonists that are effective in models of chronic painAndrew J Culshaw
Novartis Institutes for BioMedical Research, London WC1E 6BS, UK
J Med Chem 49:471-4. 2006..We also demonstrate that one compound is active in vivo against capsaicin-induced hyperalgesia and in models of neuropathic and nociceptive pain in the rat...
Universal varicella vaccination. CommentKristine Macartney
Med J Aust 183:278-9. 2005
Mapping immunisation coverage and conscientious objectors to immunisation in NSWBrynley Hull
National Centre for Immunisation Research, The University of Sydney and the Children's Hospital at Westmead
N S W Public Health Bull 14:8-12. 2003
Should dexamethasone be part of routine therapy of bacterial meningitis in industrialised countries?Peter McIntyre
National Centre for Immunisation, Research and Surveillance of Vaccine Preventable Diseases, The Children s Hospital at Westmead, NSW, Australia
Adv Exp Med Biol 568:189-97. 2005..16). Unless clear protocols are in place, the commencement of steroids before or with antibiotics will be difficult to implement in emergency situations, as illustrated by the data from Sydney...
Improving uptake of MMR vaccinePeter McIntyre
BMJ 336:729-30. 2008
